A detailed history of Nordea Investment Management Ab transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 67,546 shares of SRPT stock, worth $7.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,546
Previous 56,731 19.06%
Holding current value
$7.84 Million
Previous $7.09 Million 15.91%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025

BUY
$104.54 - $137.94 $1.13 Million - $1.49 Million
10,815 Added 19.06%
67,546 $8.21 Million
Q3 2024

Nov 05, 2024

SELL
$124.33 - $156.75 $331,961 - $418,522
-2,670 Reduced 4.49%
56,731 $7.09 Million
Q2 2024

Aug 08, 2024

SELL
$113.33 - $163.85 $255,672 - $369,645
-2,256 Reduced 3.66%
59,401 $9.39 Million
Q1 2024

May 02, 2024

BUY
$93.7 - $141.53 $3.16 Million - $4.77 Million
33,711 Added 120.63%
61,657 $7.98 Million
Q4 2023

Jan 10, 2024

SELL
$67.31 - $124.76 $23,558 - $43,666
-350 Reduced 1.24%
27,946 $2.69 Million
Q3 2023

Nov 13, 2023

BUY
$102.5 - $123.59 $1,230 - $1,483
12 Added 0.04%
28,296 $3.43 Million
Q2 2023

Jul 07, 2023

BUY
$106.4 - $157.19 $1.78 Million - $2.64 Million
16,774 Added 145.73%
28,284 $3.24 Million
Q1 2023

Apr 19, 2023

BUY
$117.53 - $155.99 $1.35 Million - $1.8 Million
11,510 New
11,510 $1.59 Million
Q2 2021

Jul 16, 2021

SELL
$69.38 - $86.75 $221,530 - $276,992
-3,193 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$127.12 - $172.34 $405,894 - $550,281
-3,193 Reduced 50.0%
3,193 $458,000
Q2 2020

Aug 13, 2020

BUY
$93.0 - $171.7 $296,949 - $548,238
3,193 Added 100.0%
6,386 $1.02 Million
Q4 2019

Feb 11, 2020

SELL
$76.53 - $135.58 $164,233 - $290,954
-2,146 Reduced 40.19%
3,193 $415,000
Q3 2019

Nov 13, 2019

BUY
$72.81 - $156.91 $388,732 - $837,742
5,339 New
5,339 $400,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.2B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.